Back to search

Article

Imatinib mesylate reduces c-Myc translocation in double-hit lymphoma cells by suppressing inducible cytidine deaminase

2024-05-31

Abstract excerpt

<title>Abstract</title> <p>Double-hit lymphoma (DHL) with c-Myc gene translocation is highly aggressive and has a poor prognosis. In DHL cells, activation-induced cytidine deaminase (AID) promotes antibody class switch recombination (CSR), ultimately leading to c-Myc gene translocation caused by Myc/IgH DNA double-strand breaks. In this study, imatinib mesylate downregulated the AID and c-Myc proteins in patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec955969-a235-5678-8735-baf5c4c7bb3a
DOI
10.21203/rs.3.rs-4368255/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Imatinib mesylate reduces c-Myc translocation in double-hit lymphoma cells by suppressing inducible cytidine deaminaseDOI 10.21203/rs.3.rs-4368255/v1
Select a neighboring publication to make it the new centre.